Autoimmune Enteropathy: A Patient Guide
At a Glance
Autoimmune enteropathy is a rare immune disorder that damages the small intestine and can cause severe diarrhea, dehydration, weight loss, and poor growth. Diagnosis often requires biopsy and careful exclusion of similar conditions, while treatment combines immune suppression with intensive nutrition support.
Autoimmune enteropathy (AIE) is an ultra-rare condition characterized by an inappropriate immune system attack on the lining of the small intestine. In a healthy body, the immune system helps protect the digestive tract; in AIE, however, immune cells mistakenly target the delicate, finger-like projections called villi that are responsible for absorbing nutrients from food. This persistent attack causes the villi to flatten and disappear, severely impairing the body’s ability to take in water, calories, and essential vitamins. The hallmark of the condition is severe, “intractable” diarrhea that does not improve with standard dietary changes, often resulting in significant weight loss or a failure to grow in children [1][2].
What I Should Do Today
- Contact your treating team promptly to establish a coordinated plan of care.
- Protect hydration and nutrition, but do not make major dietary or medication changes alone.
- Know the urgent symptoms: If you or your child experience fainting, confusion, very dark or little urine, rapid heartbeat, inability to keep fluids down, blood in the stool, or worsening abdominal pain (or for a child, markedly fewer wet diapers, no tears, or unusual sleepiness), seek emergency care immediately.
Because AIE is so rare, the process of reaching a diagnosis is often a complex journey of exclusion. It is frequently mistaken for more common conditions, such as celiac disease or certain immunodeficiencies, because they all share the same pattern of intestinal damage. To find the correct answer, doctors must look deep into the microscopic details of intestinal biopsies, interpreting supportive findings alongside your clinical history. Distinguishing AIE from its mimics is a critical first step, as the treatments required for AIE are far more intensive than those used for common digestive disorders [3][4].
The nature of the condition often depends on when it first appears, with researchers identifying distinct pediatric and adult-onset forms. In infants, AIE is frequently “syndromic,” meaning it is part of a broader genetic disorder—such as IPEX syndrome—that affects multiple organ systems, including the skin and the hormone-producing glands. In these cases, the body lacks the specific genetic “peacekeepers” needed to restrain the immune system. In adults, the condition is more likely to be an isolated autoimmune event or associated with other established autoimmune diseases, requiring a tailored diagnostic approach that often includes genetic testing for younger patients [5][6].
Managing AIE requires a dual approach that addresses both the immune system and the body’s immediate survival needs. Treatment typically begins with powerful medications to suppress the overactive immune response and allow the intestinal lining a chance to heal. Simultaneously, because the gut may be too damaged to absorb food adequately, many patients require intensive nutritional support, such as total parenteral nutrition (TPN), which delivers nutrients directly into the bloodstream. This comprehensive strategy aims to stabilize the body while the immune-suppressing medications work to achieve long-term remission [7][8].
Living with AIE is a chronic process of careful monitoring and adaptation. Once the initial inflammation is under control, the focus shifts to maintaining “mucosal healing” through individualized follow-up and blood work to track nutritional markers. Because the medications used to manage AIE “turn down” the immune system, patients and their care teams must remain vigilant against the risk of infections and other long-term side effects. While the diagnosis is life-changing, a dedicated multidisciplinary team can help navigate these challenges, focusing on restoring the health of the intestine and improving the patient’s quality of life [9][10].
In this guide
6 chapters
Understanding Autoimmune Enteropathy
Learn how autoimmune enteropathy causes diarrhea, malabsorption, and villous atrophy, how it is diagnosed, and why hydration and nutrition need specialist care.
Distinguishing AIE from Celiac and Other Mimics
Learn how autoimmune enteropathy differs from celiac disease, CVID, and drug-induced enteropathy using biopsy findings, immune tests, and antibody results.
Subtypes and Genetics: IPEX vs Adult-Onset AIE
Learn how pediatric and adult autoimmune enteropathy differ, including IPEX, FOXP3, CTLA4, STAT3, genetic testing, genetic counseling, and HSCT to guide care.
Understanding Your Intestinal Biopsy
Learn how to read an autoimmune enteropathy biopsy report, including villous blunting, crypt apoptosis, missing cells, IELs, and clues that rule out mimics.
Specialist-Directed Treatment and Nutritional Support
Learn how autoimmune enteropathy is treated with steroids, immunosuppressants, biologics, TPN, and nutrition support, with monitoring for treatment risks.
Living with AIE and Monitoring
Learn how autoimmune enteropathy (AIE) monitoring covers nutrition, relapse, infection risks, bone health, diarrhea, and ostomy output for safer care.
Common questions in this guide
What is autoimmune enteropathy, and how does it affect the body?
How do doctors diagnose autoimmune enteropathy?
What treatments are used for autoimmune enteropathy?
Could IPEX syndrome be related to autoimmune enteropathy in a child?
What should I watch for if autoimmune enteropathy causes dehydration?
How is autoimmune enteropathy monitored over the long term?
Get notified when new evidence is published on Primary autoimmune enteropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
Advances and challenges in diagnosing and managing adult autoimmune enteropathy.
Christodoulidis G, Agko SE, Kouliou MN, et al.
World journal of gastroenterology 2025; (31(2)):99118 doi:10.3748/wjg.v31.i2.99118.
PMID: 39811507 - 2
Pediatric autoimmune disorders with gastrointestinal expressions: from bench to bedside.
Francalanci P, Cafferata B, Alaggio R, et al.
Pathologica 2022; (114(1)):32-39 doi:10.32074/1591-951X-339.
PMID: 34856606 - 3
Clinical manifestations, diagnosis and long-term prognosis of adult autoimmune enteropathy: Experience from Peking Union Medical College Hospital.
Li MH, Ruan GC, Zhou WX, et al.
World journal of gastroenterology 2024; (30(19)):2523-2537 doi:10.3748/wjg.v30.i19.2523.
PMID: 38817655 - 4
Relieving the discrimination dilemma of adult autoimmune enteropathy and common variable immunodeficiency disease: two rare causes of chronic diarrhea and small intestinal villous atrophy.
Li M, Wang Q, Chen Y, et al.
Clinical rheumatology 2025; (44(8)):3353-3367 doi:10.1007/s10067-025-07523-8.
PMID: 40622608 - 5
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review.
Park JH, Lee KH, Jeon B, et al.
Autoimmunity reviews 2020; (19(6)):102526 doi:10.1016/j.autrev.2020.102526.
PMID: 32234571 - 6
Adult-Onset Autoimmune Enteropathy in an European Tertiary Referral Center.
van Wanrooij RLJ, Neefjes-Borst EA, Bontkes HJ, et al.
Clinical and translational gastroenterology 2021; (12(8)):e00387 doi:10.14309/ctg.0000000000000387.
PMID: 34333499 - 7
Isolated Intestine Transplantation for Autoimmune Enteropathy: A Case Report.
Soma D, Saxena R, Arman ME, et al.
Transplantation proceedings 2020; (52(9)):2835-2838 doi:10.1016/j.transproceed.2020.08.007.
PMID: 32854966 - 8
Adult autoimmune enteropathy in autoimmune hepatitis patient. Case report and literature review.
Iaquinto G, Panico L, Luongo G, et al.
Clinics and research in hepatology and gastroenterology 2021; (45(3)):101673 doi:10.1016/j.clinre.2021.101673.
PMID: 33744411 - 9
Comprehensive insights into pathogenesis, diagnosis, treatment, and prognosis in adult autoimmune enteropathy.
Li M, Xu T, Ruan G, et al.
Orphanet journal of rare diseases 2025; (20(1)):208 doi:10.1186/s13023-025-03731-2.
PMID: 40317016 - 10
Successful Treatment of Refractory Autoimmune Enteropathy With Ustekinumab.
Scheid JF, Misdraji J, Nath BJ, Yarze JC
ACG case reports journal 2021; (8(1)):e00520 doi:10.14309/crj.0000000000000520.
PMID: 33457439
This page provides general information about autoimmune enteropathy, its diagnosis, treatment, and supportive care; it is not medical advice. Your treating team should guide urgent care, nutrition, and medication decisions for you or your child.